FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2988311627> ?p ?o ?g. }

• W2988311627 endingPage "101860" @default.
• W2988311627 startingPage "101860" @default.
• W2988311627 abstract "Background Multiple sclerosis (MS) typically arises in early/middle adulthood and is characterized by a progressive disability of the central nervous system (CNS). Currently approved therapies do not promote tissue repair or stop disease progression. Emerging data demonstrate that stem cells present a great potential in regenerative medicine and, consequently, have also been widely investigated as a potential treatment for MS. Therefore, the aim of this study was to conduct a systematic review to inquire into the safety, tolerability, and efficacy of mesenchymal stem cells (MSCs) therapies in MS. Methods Three electronic databases (Web of Science, PubMed, and Cochrane) were searched from April until June 2019. Clinical trials or case reports with information related to the effects of MSC therapies in MS patients were considered for this review. Results 10 manuscripts were selected, namely 7 uncontrolled clinical trials, 2 randomized controlled clinical trials, and 1 case report. The overall quality of the studies was considered good. Besides minor adverse events (AEs), it was reported one case of encephalopathy with seizures and two cases of iatrogenic meningitis, which were not related to the treatment, but with the administration route. The analyses of the expanded disability status scale (EDSS) in the uncontrolled clinical trials demonstrated that 48 patients improved, 39 maintained and 16 worsened their clinical condition. Regarding the randomized studies, one did not show statistically significant variations in the mean EDSS score and in the other the mean EDSS score was statistically significantly lower for the experimental group. The case report also showed an improvement in the EDSS score. Conclusions MSCs transplantation proved to be a safe and tolerable therapy. Their potential therapeutic benefits were also validated. However, larger placebo controlled blinded clinical trials will be required to establish the long term safety and efficacy profile of these therapies for MS. Their translation into the clinical practice can provide a new hope for the patients of this highly debilitating disease." @default.
• W2988311627 created "2019-11-22" @default.
• W2988311627 creator A5000231154 @default.
• W2988311627 creator A5002940660 @default.
• W2988311627 creator A5026607138 @default.
• W2988311627 creator A5035957663 @default.
• W2988311627 date "2020-02-01" @default.
• W2988311627 modified "2023-10-14" @default.
• W2988311627 title "Growing evidence supporting the use of mesenchymal stem cell therapies in multiple sclerosis: A systematic review" @default.
• W2988311627 cites W1485262693 @default.
• W2988311627 cites W1651867145 @default.
• W2988311627 cites W1918002795 @default.
• W2988311627 cites W1967750892 @default.
• W2988311627 cites W2018321131 @default.
• W2988311627 cites W2024571049 @default.
• W2988311627 cites W2030568509 @default.
• W2988311627 cites W2038054049 @default.
• W2988311627 cites W2063638559 @default.
• W2988311627 cites W2066210998 @default.
• W2988311627 cites W2069307274 @default.
• W2988311627 cites W2105089616 @default.
• W2988311627 cites W2122847965 @default.
• W2988311627 cites W2138093663 @default.
• W2988311627 cites W2148455753 @default.
• W2988311627 cites W2150291254 @default.
• W2988311627 cites W2154677662 @default.
• W2988311627 cites W2156969855 @default.
• W2988311627 cites W2159873771 @default.
• W2988311627 cites W2231840137 @default.
• W2988311627 cites W2463810424 @default.
• W2988311627 cites W2467511189 @default.
• W2988311627 cites W2530110801 @default.
• W2988311627 cites W2549644306 @default.
• W2988311627 cites W2555514711 @default.
• W2988311627 cites W2556611242 @default.
• W2988311627 cites W2605062403 @default.
• W2988311627 cites W2626808697 @default.
• W2988311627 cites W2738829557 @default.
• W2988311627 cites W2793703980 @default.
• W2988311627 cites W2804567596 @default.
• W2988311627 cites W2888476885 @default.
• W2988311627 cites W2930641190 @default.
• W2988311627 cites W2937431312 @default.
• W2988311627 cites W4211090999 @default.
• W2988311627 cites W4230052474 @default.
• W2988311627 doi "https://doi.org/10.1016/j.msard.2019.101860" @default.
• W2988311627 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31765999" @default.
• W2988311627 hasPublicationYear "2020" @default.
• W2988311627 type Work @default.
• W2988311627 sameAs 2988311627 @default.
• W2988311627 citedByCount "11" @default.
• W2988311627 countsByYear W29883116272020 @default.
• W2988311627 countsByYear W29883116272021 @default.
• W2988311627 countsByYear W29883116272022 @default.
• W2988311627 countsByYear W29883116272023 @default.
• W2988311627 crossrefType "journal-article" @default.
• W2988311627 hasAuthorship W2988311627A5000231154 @default.
• W2988311627 hasAuthorship W2988311627A5002940660 @default.
• W2988311627 hasAuthorship W2988311627A5026607138 @default.
• W2988311627 hasAuthorship W2988311627A5035957663 @default.
• W2988311627 hasBestOaLocation W29883116272 @default.
• W2988311627 hasConcept C126322002 @default.
• W2988311627 hasConcept C142724271 @default.
• W2988311627 hasConcept C143998085 @default.
• W2988311627 hasConcept C168563851 @default.
• W2988311627 hasConcept C197934379 @default.
• W2988311627 hasConcept C198826908 @default.
• W2988311627 hasConcept C203014093 @default.
• W2988311627 hasConcept C2778375690 @default.
• W2988311627 hasConcept C2780640218 @default.
• W2988311627 hasConcept C2780892749 @default.
• W2988311627 hasConcept C28328180 @default.
• W2988311627 hasConcept C535046627 @default.
• W2988311627 hasConcept C54355233 @default.
• W2988311627 hasConcept C71924100 @default.
• W2988311627 hasConcept C86803240 @default.
• W2988311627 hasConceptScore W2988311627C126322002 @default.
• W2988311627 hasConceptScore W2988311627C142724271 @default.
• W2988311627 hasConceptScore W2988311627C143998085 @default.
• W2988311627 hasConceptScore W2988311627C168563851 @default.
• W2988311627 hasConceptScore W2988311627C197934379 @default.
• W2988311627 hasConceptScore W2988311627C198826908 @default.
• W2988311627 hasConceptScore W2988311627C203014093 @default.
• W2988311627 hasConceptScore W2988311627C2778375690 @default.
• W2988311627 hasConceptScore W2988311627C2780640218 @default.
• W2988311627 hasConceptScore W2988311627C2780892749 @default.
• W2988311627 hasConceptScore W2988311627C28328180 @default.
• W2988311627 hasConceptScore W2988311627C535046627 @default.
• W2988311627 hasConceptScore W2988311627C54355233 @default.
• W2988311627 hasConceptScore W2988311627C71924100 @default.
• W2988311627 hasConceptScore W2988311627C86803240 @default.
• W2988311627 hasLocation W29883116271 @default.
• W2988311627 hasLocation W29883116272 @default.
• W2988311627 hasOpenAccess W2988311627 @default.
• W2988311627 hasPrimaryLocation W29883116271 @default.
• W2988311627 hasRelatedWork W1871570547 @default.
• W2988311627 hasRelatedWork W1982594744 @default.
• W2988311627 hasRelatedWork W2001146581 @default.

• next